GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » EV-to-Revenue

Intervacc AB (OSTO:IVACC) EV-to-Revenue : 27.79 (As of May. 21, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Intervacc AB's enterprise value is kr222.74 Mil. Intervacc AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr8.02 Mil. Therefore, Intervacc AB's EV-to-Revenue for today is 27.79.

The historical rank and industry rank for Intervacc AB's EV-to-Revenue or its related term are showing as below:

OSTO:IVACC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.02   Med: 43.52   Max: 904.27
Current: 27.79

During the past 10 years, the highest EV-to-Revenue of Intervacc AB was 904.27. The lowest was 1.02. And the median was 43.52.

OSTO:IVACC's EV-to-Revenue is ranked worse than
71.14% of 1043 companies
in the Biotechnology industry
Industry Median: 8.21 vs OSTO:IVACC: 27.79

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Intervacc AB's stock price is kr4.105. Intervacc AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.12. Therefore, Intervacc AB's PS Ratio for today is 34.21.


Intervacc AB EV-to-Revenue Historical Data

The historical data trend for Intervacc AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB EV-to-Revenue Chart

Intervacc AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.11 519.79 487.17 130.87 48.81

Intervacc AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.87 49.04 31.75 16.42 48.81

Competitive Comparison of Intervacc AB's EV-to-Revenue

For the Biotechnology subindustry, Intervacc AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intervacc AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intervacc AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Intervacc AB's EV-to-Revenue falls into.



Intervacc AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Intervacc AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=222.737/8.015
=27.79

Intervacc AB's current Enterprise Value is kr222.74 Mil.
Intervacc AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intervacc AB  (OSTO:IVACC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Intervacc AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.105/0.12
=34.21

Intervacc AB's share price for today is kr4.105.
Intervacc AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intervacc AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Intervacc AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Intervacc AB (OSTO:IVACC) Business Description

Traded in Other Exchanges
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines